Hints and tips:
...Tesla, Pfizer, Nike, Nvidia and PayPal have come to market....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...He joins Baird from Société Générale, where he was the head of financial sponsors business in Germany and Austria....
...Middle-market focused investment bank Baird has hired Ralph von Selzam as a managing director in Europe....
...The software sales were driven by an over 94 per cent increase in next-generation titles such as Activision’s Call of Duty: Advanced Warfare and Rockstar’s Grand Theft Auto V....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...The Dow was helped by drugmaker Pfizer, which gained 1.7 per cent to $31.25. Although revenue for the pharmaceutical company fell, earnings per share of 58 cents beat expectations....
...Take the hair: Sam McKnight moussed it up with Pantene Pro-V Moisture Soufflé (£4.49), dried it off, then repeated the whole process to create more volume, before tying it into a messy pony-tail, pinning...
...Pfizer , the world’s largest drugmaker, rose 1.5 per cent to $22.50 after a note from analysts at Goldman Sachs said that the company was willing to consider “separations beyond Animal Health and Nutrition...
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...“Stock market sellers had been held in check by the prospect of a debt ceiling relief rally,” said William Delwiche, investment strategist at Baird....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Athersys shares more than doubled to $2.40 while Pfizer, the world’s largest drugmaker, was up 1.7 per cent to $18.61....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition